RESEARCH: The Lancet Oncology: Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Experts in late effects screening from the United States and Europe completed a combined review of current guidelines that direct screening for heart problems in survivors of childhood cancer. Participants in the project included representatives from the following survivorship cooperative groups: 1) the North American Children’s Oncology Group (COG); 2) the Dutch Childhood Oncology Group (DCOG); 3) the Scottish Intercollegiate Guidelines Network (SIGN); and 4) the UK Children’s Cancer and Leukaemia Group (UKCCLG). Because there previously existed a diverse range of clinical follow-up, experts reviewed the available evidence and graded recommendations based on the strength of each recommendation. For the scope of this report, we will focus on the nine consensus recommendations made by this group of experts – those with the strongest evidence and lowest level of uncertainty.
